Introduction
Colon carcinoma is the most common gastrointestinal cancer and the second most common cancer overall in the United States ( 1 ). The estimated 152,000 new cases and 57,000 deaths from the disease during 1993 alone illustrate its impact on cancer-associated morbidity and mortality. The risk of colon cancer is particularly high in ulcerative colitis (UC),' a chronic inflammatory disease of the colon. The cumulative risk is 0.5-1%/yr after the first 10 yr ofdisease (e.g., 10-20% after 30 yr of colitis involving the entire colon) and the relative risk is 15-fold higher than expected in age-matched populations without colitis (2, 3) .
The cellular oncogene c-src and its viral homologue v-src (the transforming gene of Rous sarcoma virus) encode 60-kD cytoplasmic, membrane-associated, protein tyrosine kinases (4) (5) (6) (7) (8) . For the viral protein (v-Src) or transforming mutants of the cellular protein (Src), a close correlation exists between elevated tyrosine kinase activity and malignant transformation of cells. Src activity is elevated in three human cancers: colon and breast adenocarcinomas, and neuroblastoma (9) (10) (11) (12) . Previously, we observed that Src from 13 of 21 primary colon carcinomas had 5-7-fold higher activity than Src from normal adjacent mucosa. Similarly, Src from 6 of 9 colon carcinoma cell lines had 5-20-fold higher activity than that from normal colonic cells ( 12) . Moreover, only those colon carcinoma cell lines with elevated Src activity had elevated levels of three phosphotyrosine-containing proteins, thereby suggesting a functional correlation for the increased Src tyrosine kinase activity. We also observed increased Src activity in colonic adenomas containing focal carcinoma, and in benign adenomas at greatest risk for developing cancer (those with large size, villous architecture, and/or severe dysplasia) ( 13) . Interestingly, segments offetal rat colon infected with a v-src-containing retrovirus and implanted in syngeneic pups developed significant dysplasia throughout the colonic epithelia ( 14) .
Dysplasia is a precursor to carcinoma in adenomas and in UC. To determine whether Src activity is elevated in precancerous UC tissue as it is in adenomas, we measured its kinase activity in normal, acute or chronically inflamed, dysplastic and malignant epithelia from 35 UC patients. Src activity in malignant or dysplastic epithelia was significantly higher than that in nondysplastic epithelia from the same individual. Moreover, the level of Src activity in dysplastic epithelia correlated with the degree of dysplasia: the more severe the dysplasia, the higher the Src activity. 1-5) . In contrast, Src activity in severe quiescent colitis (lanes 6 or 7) was two-to threefold higher than that in mild quiescent colitis (lanes [1] [2] [3] [4] [5] .
Methods
Src tyrosine kinase activity in dysplastic UC epithelia. Patient 3 ( Fig. 2 A) had universal UC for 11 yr. Severe quiescent colitis was present throughout the colon. In addition, mild dysplasia or LGD was present in the right colon (cecum, ascending, and proximal transverse colon). Src activity in the dysplastic epithelia (lanes 1-3) was, on average, threefold higher as measured by enolase phosphorylation or fivefold higher as measured by autophosphorylation than Src activity in the nondysplastic severe quiescent colitis (lanes [4] [5] [6] [7] [8] . Src protein levels (Fig. 3 B) were determined by immunoblot analysis. mAb 327 immunoprecipitates, performed in parallel with those used for the kinase assays shown in Fig. 3 A, were resolved by SDS-PAGE before being transferred to a nitrocellulose membrane. Two proteins were detected in each lane: the upper one is Src, the lower is mAb 327 immunoglobulin heavy chain ( 12, 13) . Src protein levels were highest in the carcinoma, and higher in epithelia containing HGD than in that containing LGD. Overall, in this patient and in others, Src protein levels correlated with Src kinase activity, and increased protein expression accounted for most of the increased kinase activity.
Patient 7 (Fig. 4) had UC for 15 yr. Multiple biopsies obtained at colonoscopy, and later at colectomy, contained chronic active colitis, and therefore, most were indefinite for dysplasia. A region of flat cecal mucosa was suspicious for HGD, and two, < 0.5 cm, raised lesions in the cecum contained HGD. In addition, a 1.5-cm, firm, nodular lesion in the cecum, and 1 of > 50 lymph nodes examined, contained mucinous adenocarcinoma (Duke's Cl ). Src activity in either of the high-grade dysplasia-associated lesions or masses (DALMs) was threefold higher than that in flat mucosa containing HGD (compare lanes 2 or 3 with lane 4). Src activity in the carcinoma was five-or sevenfold higher (as measured by autophosphorylation or enolase phosphorylation, respectively) than that in HGD (compare lanes I and 4) .
Recently, we examined the tyrosine kinase activity of Srcrelated proteins (Yes, Lck, Fyn, Hck, Lyn, and Fgr) in human colon carcinoma. We observed that c-Yes activity, like that of Src, and unlike that of other family members, was significantly elevated in most carcinomas (26) and in benign adenomas at greatest risk for cancer (C. A. Cartwright, S. Pena, and A. I. Meisler, unpublished observations). Here we measured the protein-tyrosine kinase activity of Yes in the neoplastic UC epithelia ofpatient 7 (Fig. 4, lanes 5-8) . Anti-Yes immunoprecipitates were prepared from those lysates used for the Src protein kinase assays shown in lanes 1-4. We observed that Yes was present in the distal colon (70 and 80 cm from the cecum), and HGD was present in the remainder of the colon. In addition, a sessile 1.5-cm polypoid lesion in the transverse colon (35 cm), and 1 of96 lymph nodes examined, contained moderately differentiated adenocarcinoma. The tumor stage was C by the Astler-Coller modification of the Dukes' classification (24, 25) . Src activity (A) in epithelia containing HGD was higher (on average, fourfold as measured by enolase phosphorylation, or sixfold as measured by autophosphorylation) than Src activity in epithelia containing LGD. Src activity in the carcinoma was 6-or 10-fold higher than that in epithelia containing LGD, and -2-fold higher than that in epithelia containing HGD. In contrast, Src activity in severe quiescent colitis was higher (2.6-fold as measured by autophosphorylation, or 2.5-fold as measured by enolase phosphorylation) than that in mild quiescent colitis. Src activity in LGD was 10-or 6.1-fold higher, and that in HGD/DALM or carcinoma in situ was 20.9-or 22.8-fold higher than that in mild quiescent colitis. Thus, Src activity is elevated in dysplastic UC epithelia. In addition, Src activity in nondysplastic severe chronic colitis is significantly higher than that in mild chronic or active colitis, or normal epithelia. Data from two additional UC patients who had LGD, HGD, DALMs, and carcinomas are summarized in Fig. 5 B.
Because these two patients had no mild quiescent colitis for comparison, their data could not be analyzed with those shown in Fig. 5 A. Values are expressed relative to those for HGD. Src activity in HGD was 6.3-or 3.9-fold higher (as measured by autophosphorylation or enolase phosphorylation, respectively) than that in LGD. Src activity in HGD/DALMs was 2.6-or 2.9-fold higher than that in HGD in flat epithelia. Finally, Src activity in carcinomas was 3.4-or 4.5-fold higher than that in HGD. Thus, the level of Src activity correlates with the degree of dysplasia: the more severe the dysplasia, the higher the Src activity. Moreover, Src activity in HGD-associated lesions is intermediate between that in invasive carcinoma and that in HGD in flat epithelia.
Six patients had active colitis that was indefinite for dysplasia at year 1, and inactive quiescent colitis that was negative for dysplasia in the same regions ofthe colon on follow-up evaluation at year 2 (and for two patients, again at year 3). In all six patients, Src activity measured in the active colitis at year 1 was very similar to that measured in the inactive colitis in the same region at year 2 (and for the two patients, again at year 3). Thus, Src activity remained constant in epithelia that initially were indefinite for dysplasia because of active colitis, and later, when the colitis was quiescent, were clearly and reproducibly negative for dysplasia.
Discussion
The data show that Src tyrosine kinase activity and protein abundance are elevated in neoplastic UC epithelia. Activity is highest in malignant and severely dysplastic epithelia, and 6-10-fold higher in mildly dysplastic than in nondysplastic epithelia. Thus, Src activity is elevated in premalignant UC epithelia, which is at greatest risk for developing cancer. The data suggest that activation of the src proto-oncogene is an early event in the genesis of UC colon cancer. Several groups have identified genes whose structure, expression, or activity is altered in different stages of sporadic colon cancer (27) . A number of genes are affected relatively late in tumorigenesis, i.e., in carcinomas. These include the putative tumor suppressor genes p53 and DCC (28) (29) (30) . Other genes, like the dominant acting oncogene K-ras, seem to be altered earlier in tumorigenesis, in adenomas with a high malignant potential (31 ) . We have shown that the Src and Yes tyrosine kinase activities and protein levels are elevated both in carcinomas and in adenomas (12, 13, 26) . Expression of members of the myc gene family is abnormal in essentially all adenomas, independent of their malignant potential (32, 33) . Mutations of the APC locus may represent one of the earliest events in the genesis of colon cancer (34) (35) (36) (37) (38) .
Src and myc are overexpressed in many of the same colon carcinomas and adenomas ( 12, 13, 32, 33) . Interestingly, segc-Src Kinase Activity in Premalignant Epithelia of Ulcerative Colitis 513 1 ments of fetal rat colon infected with a myc-containing retrovirus and implanted in syngeneic pups develop epithelial atypia and focal dysplasia ( 14) . Segments infected with a v-src-containing retrovirus develop more significant dysplasia throughout the colonic epithelia. Moreover, the segments infected with both oncogenic retroviruses together develop HGD and in one case adenocarcinoma. Thus, myc and src may act synergistically to induce dysplasia.
Genetic alterations in premalignant UC epithelia include p53 point mutations and loss of heterozygosity (39, 40) , Myc (41 ) , and Src overexpression, and, rarely, ras mutations (42) (43) (44) (45) . p53 inactivation and Src overexpression occur earlier in the histologic progression of neoplasia in UC than in sporadic colon cancer. These observations suggest that the etiology and pathogenesis of sporadic and UC-associated carcinogenesis may differ in significant ways.
Colonic mucosa consists of epithelia and lamina propria. Normally the lamina propria contains lymphocytes, plasma and mast cells, macrophages, eosinophils, and fibroblasts. In quiescent UC, mononuclear cells (predominantly lymphocytes and plasma cells) infiltrate the lamina propria. It is possible that the increased Src activity measured in severe quiescent colitis is actually Src activity measured in these infiltrating cells. However, lymphocytes and plasma cells do not express Src, and macrophages express it at very low levels (46, 47) . Therefore, it seems unlikely that these cells are contributing significantly to the Src activity in severe quiescent colitis. The cell population in the lamina propria of dysplastic mucosa is not significantly different than that in nondysplastic mucosa, and thus, cannot explain the striking differences observed in Src activity between these mucosae. In active UC, polymorphonuclear cells infiltrate the lamina propria. Again, it is possible that the Src activity measured reflects that found in these acute inflammatory cells. Although the level of Src activity in neutrophils is not known, Src activity measured in active colitis is remarkably similar to that in normal mucosa or mild quiescent colitis (Fig. 5 A) despite the varied numbers and types of inflammatory cells present in these different mucosae.
Src protein kinase activity and abundance decrease as human colon carcinoma cell lines differentiate in response to sodium butyrate (48 The recent discovery of widespread mutations in short, repeated DNA sequences in colon cancer reveals a novel mechanism of carcinogenesis distinct from those involving activated oncogenes or inactivated tumor suppressor genes (5 1-53) . The data suggest the presence of a defective DNA replication factor resulting in reduced fidelity for replication or repair. Clearly, multiple, complex molecular mechanisms are involved in colonic carcinogenesis. Activation of the Src tyrosine kinase may be only one of a number of factors contributing to malignant transformation and may not be sufficient in itself to transform cells. Nonetheless, the consistent and striking nature of its activation in malignant and premalignant UC epithelia, together with the strong historical correlate of elevated Src activity and cell transformation, suggest that activation of this kinase may be an important early event in the genesis of UC colon cancer.
